Merz Therapeutics North America has launched “Celebrating the Fighters,” a nationwide U.S. community campaign honoring the resiliency and courage of people with Parkinson’s disease. The campaign features several initiatives, including a national TV ad, and offers social media and advocacy resources. It leverages the resilience and spirit of…
News
Parkinson’s disease may actually begin deep in the gut, where immune cells meant to protect the body inadvertently help toxic proteins make their way to the brain, according to a new study. Researchers at the UK Dementia Research Institute at University College London (UCL) have identified a specific type…
Small particles called exosomes may help deliver curcumin directly to dopamine-producing nerve cells damaged in Parkinson’s disease, a study in rats suggests. In laboratory and animal experiments, the targeted delivery helped protect these cells and was associated with improved outcomes, pointing to a potential precision-delivery strategy for future research.
Boston University has been awarded a $2 million research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support a clinical study examining motor and cognitive factors related to changes in walking among people with Parkinson’s disease who use MedRhythms’ music-based platform, MOVIVE. MOVIVE…
Researchers at Case Western Reserve University in Cleveland, Ohio, developed a new compound that blocks a harmful interaction between the alpha-synuclein protein and a mitochondrial enzyme called ClpP. In a mouse model of Parkinson’s disease, the treatment helped preserve dopamine-producing brain cells and improved movement and cognitive performance. The…
In the Netherlands, new cases of Parkinson’s disease occur more often in men, older adults, people with higher socioeconomic status, and residents of the northern provinces, suggesting that long-term environmental factors may contribute to the disease, according to a study from Utrecht University. According to a university press…
Mair Therapeutics is collaborating with Radboud University in the Netherlands to advance Parkinson’s disease research by developing small molecules designed to target TMEM175, a protein that genetic studies have linked to Parkinson’s risk. “Parkinson’s disease remains one of the most pressing medical challenges of our time,” Vasily Kazey, PhD,…
Michael J. Fox is returning to the small screen for season three of Apple TV+’s “Shrinking.” Once again, he is using his craft to elevate awareness and understanding of Parkinson’s disease. For the actor and advocate, the role is a continuation of a mission that has shaped his life…
People with Parkinson’s disease may show subtle changes in their driving abilities even when standard cognitive tests appear normal, according to a study that used a driving simulator to detect impairments. The simulator revealed slower reaction times and reduced control of lane position — an indicator of impaired visuospatial…
In-home caregiving service provider Comforcare announced a specialized program to support people living with Parkinson’s disease and their caregivers. The Parkinson’s Pathway Program is designed to improve patients’ quality of life by providing trained caregivers to help with medication management, movement and exercise, nutrition, and emotional support. “Parkinson’s disease…
Recent Posts
- Painting a more accurate picture of being a caregiver
- Parkinson’s weight loss driven by burning fat instead of glucose
- Tips from an expert for traveling with Parkinson’s disease, part 2
- New imaging shows how exercise helps ‘normalize’ the Parkinson’s brain
- My caregiving journey started at the kitchen table